tm logo
Trademark Search
INTELLISELECT

View On IC.GC.CA

INTELLISELECT
ADVERTISED

on 11 Sep 2024

Last Applicant/ Owned by

KYMAB LIMITED

The Bennet Building (B930),Babraham Research CampusCambridge CB22 3AT

GB

Serial Number

2165317 filed on 13th Sep 2021

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

INTELLISELECT

Trademark usage description

pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimm Read More

Classification Information

Class [005]
Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; preparations for detecting genetic predispositions for medical purposes; chemical preparations for use in DNA analysis for medical use; medicines for treating diseases and disorders, namely, cancer, and immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; human vaccines; human vaccine preparations; vaccines for human use; cloned DNA from humans and animals for use in medical diagnostics.

Classification kind code

11

Class [009]
Downloadable computer software for use in scientific and pharmaceutical research and development for identifying, creating or selecting antibody or antigen binding fragment thereof, or sequences and nucleic acids encoding them; downloadable computer software for scientific modelling of antibodies and antigen binding fragment thereof; downloadable computer software for pharmaceutical modelling; downloadable computer software for research and development in the field of antibodies discovery; devices for analysing genome information.

Classification kind code

11

Class [042]
Product research and development services; design and development of hardware and software; clinical research in the field of antibodies, oncology, immunology and inflammatory diseases, namely, atopic dermatitis, asthma, esophagitis, neurology diseases, namely, multiple sclerosis, amyotrophic lateral sclerosis, hemophilia, Pompe disease, arthritis; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; structural and functional analysis of genomes; drug discovery services; laboratory research services relating to pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; biotechnology testing and research; research relating to medicines; research and development of vaccines and medicines; conducting clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research services; providing information in medical research concerning pharmaceutical substances.

Classification kind code

11

Class [044]
Medical diagnostic services; DNA screening for medical purposes; genetic analysis and reporting services for medical purposes; medical services relating to DNA, genetics and genetic testing; genetic counselling.

Classification kind code

11

Mark Details

Serial Number

2165317

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 01st Jun 2023		Search Recorded
Submitted for opposition 20
on 01st Jun 2023		Examiner's First Report
Submitted for opposition 223
on 01st Jun 2023		Total Provisional Refusal
Submitted for opposition 256
on 12th Dec 2022		Notification of Possible Opposition Sent
Submitted for opposition 48
on 30th Mar 2022		Agent Changed
Submitted for opposition 257
on 10th Feb 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 09th Feb 2022		Formalized
Submitted for opposition 1
on 09th Feb 2022		Created
Submitted for opposition 228
on 13th Sep 2021		International Registration
Submitted for opposition 30
on 13th Sep 2021		Filed